Research programme: tuberculosis therapy - Southern Research InstituteAlternative Names: Tuberculosis therapy research programme - Southern Research Institute
Latest Information Update: 26 Jun 2003
At a glance
- Originator Southern Research Institute
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 01 May 2001 New profile
- 01 May 2001 Preclinical development for Tuberculosis in USA (Unknown route)